Publications

VanderNoot N. Growing the nursing assistant workforce through expansions to the Nurse Corps Program. American Public Health Association Annual Meeting, Boston, MA, November 2022.

VanderNoot N, Weinstein A. Does chronic liver disease associate with changed levels of brain derived neurotrophic factor? George Mason University OSCAR Highlights, Fairfax, VA, May 2022.

VanderNoot N, Weinstein A. Depressive symptoms and blood analytes in chronic liver disease patients—Is there an association? George Mason University Celebration of Scholarship, Fairfax, VA, December 2021.

Kallman-Price J, VanderNoot N, Escheik C, Austin P, Estep JM, et al. Assessment of secondary sarcopenia in chronic liver disease: How good are our criteria measures? Digestive Disease Week, Virtual, May 2021. Poster with Distinction

Kallman-Price J, VanderNoot N, Escheik C, Austin P, Estep JM, et al. 2021. Association of sarcopenia, fatigue, and serum myokines in patients with chronic liver disease. Gastroenterology 160(6):S-778-779; doi: 10.1016/S0016-5085(21)02573-7.

Estep JM, VanderNoot N, Kallman-Price J, Austin P, Escheik C, et al. 2021. Circulating oncostatin concentrations are lower in NAFLD patients compared to chronic hepatitis-C patients or controls. Gastroenterology 160(6):S-783-784; doi: 10.1016/S0016-5085(21)0258809.

Kallman-Price J, VanderNoot N, Escheik C, Austin P, Estep JM, et al. 2021. Principal components analysis (PCA) in chronic liver disease (CLD) reveals three component model highlighting discrete contributions by sarcopenia criteria measures and serum myokines. Gastroenterology 160(6):S-762; doi: 10.1016/S0016-5085(21)0235-x.

Kallman-Price J, VanderNoot N, Escheik C, Austin P, Estep JM, et al. 2021. Assessment of secondary sarcopenia in chronic liver disease: How good are our criteria measures? Gastroenterology 160(6):S-829; doi: 10.1016/S00016-5085(21)02706-2.

VanderNoot N, Short MI, Fongang B. Gut microbiome meta-analysis in Parkinson’s disease. National Council for Undergraduate Research, Virtual, April 2021.

VanderNoot N, Gerber NL, Kallman-Price J. Criteria for the identification of sarcopenia and the relationship with fatigue. National Council for Undergraduate Research, Virtual, April 2021.

VanderNoot N, Gerber NL. Defining sarcopenia and measuring the effects of muscle loss. George Mason University Celebration of Scholarship, Virtual, December 2020.

Karrar A, VanderNoot N, Kallman-Price J, Austin P, Escheik C, et al. Lower human activity profiles are associated with higher fatigue score in patients with non-alcoholic fatty liver disease (NAFLD) and hepatitis C virus (HCV). American Association for the Study of Liver Diseases Liver Meeting, Virtual, November 2020.

VanderNoot N, Short MI, Fongang B. Gut microbiome meta-analysis in Parkinson’s disease. Departmental talk, University of Texas Health Sciences Center, Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Disease, Virtual, November 2020.

Gerber NL, Paik J, Younossi E, VanderNoot N, Golabi P, Younossi Z. 2020. Association between dietary factors and sarcopenia in patients with non-alcoholic fatty liver disease. Hepatology 72(S1):p1045A.

Karrar A, VanderNoot N, Kallman-Price J, Austin P, Escheik C, et al. 2020. Lower human activity profiles are associated with higher fatigue score in patients with non-alcoholic fatty liver disease (NAFLD) and hepatitis C virus (HCV). Hepatology 72(S1):p851.

Adibah N, VanderNoot N, Pollack A, Lee Y, McCombs M, et al. Gestational effects of traffic pollution in the DC metro area. Virginia Public Health Association Conference, Fairfax, VA, March 2019.

VanderNoot N, Christianson A, Schmieder A, Yeung N, Tilden A, Graber J. Unexpected, study-dependent variation in larval zebrafish pathways: Transcriptome metadata analysis on the effects of environment and/or genetics. MDI Biological Laboratory Student Symposium, Bar Harbor, ME, August 2018.